Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Fiduciary duty can be justified, but it raises many eyebrows. Lots of questions that won't be answered.
If we do not get a BE study update by Thursday I think something went awry with the study and that they are planning for a redo to hasten absorption. They'll want to put together a plan to communicate if this is the case, which would cause a short delay in a PR.
Good thing we have Trimipramine now for sure.
Good point, but either way he is set with the preferred stock dividends and side deals.
On a side note, does yesterday's PR count as main steam press? :)
Several quarters ago Nasrat used a baseball analogy - some undisclosed drugs were doubles and singles, etc. This one signifies the batter gets beamed, for the second time in the same game. At what point does the pitcher get pulled?
This is just a change of ownership. The drug is already marketed and manufactured, we just are now part owner. Knowing the gravitation towards generics as a cheaper and in most cases just as good product is a foregone conclusion that cash flow is generated on this tiny drug right away.
The road continues to be paved for the CFO to continue to tell us how well the generics are doing.
This is my new favorite quote.
Lol I am really sure The FDA really cares about a $2 million drug.
Well, if SequestOx fails to progress I am ecstatic we now have a solid backup plan: Trimipramine. It's a close second.
Yep, which makes me think they don't have results either way, for better or worse. If we get past Friday with no news I will actually be happy. Don't want to have a crappy Memorial Day weekend.
We were all intrigued last summer at the Mikah pickup and we're guessing as to what it was. Don't think any of us guessed this one. lol
I see it as a silly distraction. I see CEO continuing to line his pockets, nothing different.
Haha! Love that.
Nasrat may have created a bit of leverage against Puracap.
On the other hand, talk about top notch ethics:
http://www.fiercepharma.com/regulatory/dr-reddy-s-blasted-warning-letter-for-hiding-existence-of-testing-lab-from-fda
I don't think we have the results yet. If they were bad, with Nasrat's record I would have expected news on Friday or slipped in with this PR after the ANDA news. I think Elite is still waiting on the results. Could be good or bad.
That I agree with.
Perhaps Nasrat was doing Elite a favor after stuffing Elite on the first handoff from Mikah. :)
Not exactly the best use of time, that's for sure. CEO buys through Mikah and flips to Elite for a profit not at arms length. Crazy.
Although this will get us an inch or two closer to CFP, but won't get us past the goal line.
It did make me chuckle as I this was not the PR that we were all looking for. lol
The Memorial Day weekend did cross my mind, but I think the results lean favorable for the BE study.
Love the Bid at 0.21 and Ask at 0.20. Will be nice to one day get off the OTC.
So sorry to hear. One of my fears, and I think this is a valid fear, is that ADF tech will push oxy users to heroin & fentanyl.
Don't speak so soon. How soon to forget that Nasrat pulled the Friday evening CRL. Very coward-like. Haven't had any live Q&A since.
Regardless of what they say, it cannot be taken as truth, regardless of how positive it sounds. Do you recall all those NASDAQ promises? Safe Harbor gives them a ton of leeway in language.
You are right, but on the flip side that is management's job to instill confidence. Anything they say future related falls under Safe Harbor language and could be complete and utter BS. Their confidence could mean absolutely nothing in the end.
Yes, if you have a separate ticket to vote for in a proxy war. I have never seen a write in option, but it could exist I guess, if the company permits it. Usually you vote for the board members up for election or withhold your vote. Since this company isn't owned by institutions (primarily mgmt & retail owners) it gets much more complicated.
You can't just vote someone on a board. For companies to expand their board, board approval must be given. Shareholders vote for the company's recommended Board members periodically. If another investor wants to make a board seat recommendation that differs from the Board's recommendation, this becomes an incredibly expensive proxy war that can easily cost many millions. The client I consult for is going through this now with an aggressive activist investor.
Except for that 20% dividend kicker he just added on his preferred shares.
No David Copperfield here, except for Nasrat. He can create new shares and dividends out of thin air! Amazing!
That is absolutely hilarious...and remarkably accurate.
Ha! Didn't see the change. Per your note, I am right there with you.
I think the only holding and dumping that is going on with ELTP is taking place within a bathroom stall.
You need to call your broker to arrange what block, if different. At least I need to do so via Scottrade
Absolutely. Most companies announce news pre- or post-market, but some do during the trading session.
The study results would be a material event and would need to be PR'd.
I read this article earlier this week and the part that I found troubling was 3,900 people initiating non-medical use of opiates each day. That is unbelievably sad and scary.
But this isn't a loan. LPC has virtually zero risk with the flipping of shares. This isn't equivalent to a commercial bank taking on risk for a loan or revolver option.
LPC doesn't win by being long here. That is not how these dilutive financing companies work. This is purely a quick sales transaction. LPC gets shares and flips on the market. They win by getting their free shares for the deal, flip and sell. How does this provide any other "potential" insight?
Yes and no. LPC III came to be since the last one expired.
Many partnership deals are done with upfront payments. Would be great to see something along these lines in place of the 7.5M to prevent further dilution, but have doubts. I agree that Elite is trying to create leverage, but anyone would know that in reality the potential dilution burns a hole in the CEO's pocket (excl 20% preferred share dividend). In negotiations it doesn't seem all that plausible, but to leverage several other partnerships against each other would be the real ticket, but just not realistic at this point.